The Efficacy and Safety of γ-Linolenic Acid in the Treatment of Infantile Atopic Dermatitis

The efficacy and safety of γ-linolenic acid in the treatment of atopic dermatitis was evaluated. The children (mean age, 11.4 months) with atopic dermatitis (mean duration, 8.56 months) were openly treated with 3 g/day γ-linolenic acid, for 28 days. Clinical evaluations were carried out every 7 days, and parents were asked to keep a diary, recording details of symptoms of eczema every day. Blood chemistry and immunological tests were done before and after treatment. None of the children showed complete recovery of symptoms. A gradual improvement in erythema, excoriations and lichenification was seen; significant differences were shown for itching (P < 0.01), and the use of antihistamines (P < 0.01). A significant rise in the percentage of circulating CD8 was found. No side-effects were recorded. Dietetic and pharmacological approaches are the basis of the treatment of atopic dermatitis and γ-linolenic acid appears to be a safe and efficient additional therapy for infants and young children.

[1]  G. Hølmer,et al.  Polyunsaturated fatty acids in plasma, red blood cells and mononuclear cell phospholipids of patients with atopic dermatitis , 1992, Allergy.

[2]  J. Smolle,et al.  Morphometry in clinical dermatology. , 1992, Acta dermato-venereologica.

[3]  F. Bahmer,et al.  Quantification of the extent and the severity of atopic dermatitis: the ADASI score. , 1991, Archives of dermatology.

[4]  Daniel J. Gould,et al.  Meta‐analysis of placebo‐controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response , 1989, The British journal of dermatology.

[5]  C. Dupont,et al.  Ketotifen treatment of atopic dermatitis and other food allergy diseases * , 1989, Allergy.

[6]  J. Hanifin.  Standardized grading of subjects for clinical research studies in atopic dermatitis: workshop report. , 1989, Acta dermato-venereologica. Supplementum.

[7]  U. Reinhold,et al.  In vitro generation of IFN-gamma in relationship to in vivo concentration of IgE and IgG subclasses and Fc epsilon Rl/CD23 positive circulating lymphocytes in patients with severe atopic dermatitis (AD). , 1989, Acta dermato-venereologica. Supplementum.

[8]  A. Bordoni,et al.  Evening primrose oil (Efamol) in the treatment of children with atopic eczema. , 1988, Drugs under experimental and clinical research.

[9]  C. Carini,et al.  IgG autoantibody to IgE in atopic patients. , 1988, Annals of allergy.

[10]  Kjellman Ni.  Food allergy--treatment and prevention. , 1987 .

[11]  P. Uotila,et al.  Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins , 1987, The British journal of dermatology.

[12]  D. Horrobin,et al.  Essential fatty acids in the plasma phospholipids of patients with atopic eczema , 1984, The British journal of dermatology.

[13]  I. Strannegård,et al.  Essential fatty acids in serum lecithin of children with atopic dermatitis and in umbilical cord serum of infants with high or low IgE levels. , 1987, International archives of allergy and applied immunology.

[14]  N. Kjellman.  Food allergy--treatment and prevention. , 1987, Annals of allergy.

[15]  R. Geha,et al.  Circulating IgG autoantibodies to IgE in atopic syndromes. , 1986, The Journal of allergy and clinical immunology.

[16]  S. Wright.  Atopic dermatitis and essential fatty acids: a biochemical basis for atopy? , 1985, Acta dermato-venereologica. Supplementum.

[17]  G Hung,et al.  Stereological methods. Vol. 1: Practical methods for biological morphometry By . Academic Press, New York/London, 1979. xvi + 415 pp., $57.50 , 1984 .

[18]  R. R. Brenner.  Effect of unsaturated acids on membrane structure and enzyme kinetics. , 1984, Progress in lipid research.

[19]  M. Manku,et al.  Essential fatty acids in the plasma phospholipids of patients with atopic eczema. , 1984, The British journal of dermatology.

[20]  C. Carini,et al.  An antiglobulin: IgG anti-IgE. Occurrence and specificity. , 1983, Annals of allergy.

[21]  D. Macdonald,et al.  Quantitative analysis of T‐lymphocyte subsets in atopic eczema, using monoclonal antibodies and flow cytoafluorimetry , 1983, The British journal of dermatology.

[22]  J. Burton,et al.  ORAL EVENING-PRIMROSE-SEED OIL IMPROVES ATOPIC ECZEMA , 1982, The Lancet.

[23]  R. Camp,et al.  Prostaglandins, hydroxy fatty acids, leukotrienes and inflammation of the skin , 1982, Clinical and experimental dermatology.

[24]  D. Horrobin.  The regulation of prostaglandin biosynthesis: negative feedback mechanisms and the selective control of formation of I and 2 series prostaglandins: relevance to inflammation and immunity. , 1980, Medical hypotheses.

[25]  G. Rajka,et al.  Diagnostic Features of Atopic Dermatitis , 1980, Acta Dermato-Venereologica.

[26]  D. Horrobin,et al.  The nutritional regulation of T lymphocyte function. , 1979, Medical hypotheses.

[27]  N. Byrom,et al.  Immune status in atopic eczema: a survey , 1979, The British journal of dermatology.

[28]  E. Weibel.  Practical methods for biological morphometry , 1979 .

[29]  H. Bennich,et al.  Immunoglobulin E in dermatoses. Levels in atopic dermatitis and urticaria. , 1969, Archives of dermatology.

[30]  A. Hansen.  SERUM LIPIDS IN ECZEMA AND IN OTHER PATHOLOGIC CONDITIONS , 1937 .